Daylight photodynamic therapy vs. Conventional photodynamic therapy as skin cancer preventive treatment in patients with face and scalp cancerization: an intra‐individual comparison study
Authors:
- 13 March 2017
- journal article
- research article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 31 (8) , 1303-1307
Abstract
Background: Individuals with medical history of non‐melanoma skin cancers (NMSCs) usually develop multiple and/or recurrent malignant lesions around the site of the primary neoplasm. The latter represents the clinical expression of the ‘field cancerization’ theory; supporting the presence of multiple malignant clones of dysplastic keratinocytes over the entire epithelium that potentially can progress into clinical lesions. Taking into consideration that the burden of NMSCs on public health and health‐care cost is high, adequate control of recurrences and management of field change is challenging.Objectives: To compare the safety and efficacy of daylight photodynamic therapy (DL‐PDT) vs. conventional photodynamic therapy (C‐PDT) in the prevention of occurrence of new NMSCs in patients with clinical and histological signs of actinic field damage.Methods: Twenty‐six patients, with personal history of NMSCs on the face or scalp and actinic keratosis (AK) on the same fields, were randomized for DL‐PDT on one side and C‐PDT on the other. For a 12‐month period, individuals were clinically evaluated for development of new NMSCs.Results: The total number of new AKs and the mean time of their development did not significantly differ between the treated sides. Local adverse events were more intense with C‐PDT, and patients’ preference was more for DL‐PDT compared to C‐PDT.Conclusions: The current findings suggest equal preventive potential of DL‐PDT vs. C‐PDT against the formation of new NMSCs in patients exhibiting actinic field damage.Keywords
This publication has 17 references indexed in Scilit:
- Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapyBritish Journal of Dermatology, 2012
- Daylight photodynamic therapy for actinic keratosis: an international consensusJournal of the European Academy of Dermatology and Venereology, 2011
- The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapyPhotodermatology, Photoimmunology & Photomedicine, 2011
- Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markersBritish Journal of Dermatology, 2011
- Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled studyBritish Journal of Dermatology, 2009
- Photodynamic Therapy With Methyl Aminolevulinate for Prevention of New Skin Lesions in Transplant Recipients: A Randomized StudyTransplantation, 2008
- Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded studyBritish Journal of Dermatology, 2008
- Temperature Effect on Accumulation of Protoporphyrin IX After Topical Application of 5-Aminolevulinic Acid and its Methylester and Hexylester Derivatives in Normal Mouse Skin¶Photochemistry and Photobiology, 2007
- Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous miceBritish Journal of Dermatology, 2005
- Temperature Effect on Accumulation of Protoporphyrin IX After Topical Application of 5-Aminolevulinic Acid and its Methylester and Hexylester Derivatives in Normal Mouse Skin¶Photochemistry and Photobiology, 2002